J. Kevin Buchi - 12 May 2023 Form 4 Insider Report for Ampio Pharmaceuticals, Inc.

Role
Director
Signature
Suzette McNally, Attorney-in-Fact for J. Kevin Buchi
Issuer symbol
N/A
Transactions as of
12 May 2023
Net transactions value
+$16,370
Form type
4
Filing time
16 May 2023, 15:30:59 UTC
Previous filing
11 May 2023
Next filing
17 May 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AMPE Common Stock Purchase $5,513 +23,440 $0.2352 23,440 12 May 2023 Direct F1
transaction AMPE Common Stock Purchase $10,857 +44,026 +188% $0.2466 67,466 15 May 2023 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported is a weighted average. Shares were purchased in multiple transactions at prices ranging from $0.228 to $0.244, inclusive.
F2 The price reported is a weighted average. Shares were purchased in multiple transactions at prices ranging from $0.227 to $0.2598, inclusive.